Jeffrey R. Baxter
2023
In 2023, Jeffrey R. Baxter earned a total compensation of $893.5K as President, Chief Executive Officer at VBI Vaccines, a 51% decrease compared to previous year.
Compensation breakdown
| Option Awards | $121,736 |
|---|---|
| Salary | $697,928 |
| Other | $73,883 |
| Total | $893,546 |
Baxter received $697.9K in salary, accounting for 78% of the total pay in 2023.
Baxter also received $121.7K in option awards and $73.9K in other compensation.
Rankings
In 2023, Jeffrey R. Baxter's compensation ranked 1,295th out of 2,773 executives tracked by ExecPay. In other words, Baxter earned more than 53.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,295 out of 2,773 | 53rd |
Division Manufacturing | 781 out of 1,516 | 49th |
Major group Chemicals And Allied Products | 518 out of 855 | 39th |
Industry group Drugs | 505 out of 821 | 39th |
Industry Pharmaceutical Preparations | 348 out of 590 | 41st |
Source: SEC filing on April 29, 2024.
Baxter's colleagues
We found two more compensation records of executives who worked with Jeffrey R. Baxter at VBI Vaccines in 2023.
News
VBI Vaccines CEO Jeffrey Baxter's 2023 pay falls 51% to $894K
April 29, 2024
VBI Vaccines CEO Jeffrey Baxter's 2022 pay falls 47% to $1.8M
May 1, 2023
VBI Vaccines CEO Jeffrey Baxter's 2021 pay jumps 54% to $3.5M
April 29, 2022
VBI Vaccines CEO Jeffrey Baxter's 2020 pay jumps 63% to $2.2M
April 26, 2021
VBI Vaccines CEO Jeffrey Baxter's 2019 pay slips 8% to $1.4M
April 28, 2020
VBI Vaccines CEO Jeffrey Baxter's 2018 pay jumps 81% to $1.5M
April 29, 2019